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Abstract 
Purpose 
To investigate the possibility of auditory dysfunction in patients with Leber 
Hereditary Optic Neuropathy (LHON). 
Methods 
We prospectively recruited 10 affected patients from the North East of England 
harbouring one of the three primary mitochondrial LHON mutations (3460G>A n = 3, 
11778G>A n = 5 and 14484T>C n = 2).  A detailed auditory history was taken and 
they were asked to complete a validated hearing questionnaire.  Each patient then 
underwent a comprehensive topographic neuro-auditory assessment to evaluate both 
middle and inner ear functions and the integrity of the brainstem auditory pathways. 
Results 
We found no evidence of cochlear nerve dysfunction or abnormalities of the central 
brainstem auditory pathways in our LHON cohort and five patients had completely 
normal hearing tests.  The remainder had mild conductive hearing loss from 
childhood ear infections and/or high frequency sensorineural hearing loss from 
previous noise injury. 
Conclusion 
Although further studies are required to confirm our findings, auditory dysfunction as 
a result of a primary LHON mutation is probably uncommon. 
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Introduction 
Leber Hereditary Optic Neuropathy (LHON, OMIM 535000) is the most common 
mitochondrial genetic disease, with an estimated prevalence of 2.6-3.2 per 100,000 in 
Northern Europe (Man et al. 2003; Spruijt et al. 2006).  It is characterised by bilateral, 
subacute, painless loss of vision and over 95% of LHON cases are due to one of three 
primary mitochondrial DNA (mtDNA) point mutations: 3460G>A, 11778G>A and 
14484T>C.  Although visual failure is the defining feature of this mitochondrial 
disorder, cardiac arrhythmias and neurological abnormalities have been reported to be 
more common in LHON compared to controls (Man et al. 2002). 
Hearing loss is currently not viewed as being part of the phenotypic spectrum of 
LHON but in a recent report, Ceranic and Luxon described 2 patients with the 
G11778A mutation and bilateral hearing impairment (Ceranic and Luxon 2004).  
Based upon their auditory assessment, they concluded that these 2 patients had 
evidence of an auditory neuropathy i.e. a lesion of the cochlear nerve with normal 
cochlear function and no brainstem pathology.  An association between LHON and 
auditory dysfunction is biologically plausible given that several mtDNA mutations 
have been identified as the cause of non-syndromic deafness and hearing loss is a 
well-recognised feature of the more severe mitochondrial encephalomyopathies 
(Chinnery et al. 2000).  The aim of our study was therefore to prospectively 
investigate a larger cohort of affected patients to establish the strength of any 
association between LHON and auditory dysfunction. 
Patients and Methods 
This study was approved by the local research ethics committee and informed consent 
was obtained from all participants.  We randomly recruited 10 affected patients < 60 
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years of age from our North East of England LHON database, without prior 
knowledge of whether they had any hearing loss (Table 1).  The level of mutated 
mtDNA molecules in peripheral blood leukocytes was determined using a primer 
extension assay protocol (Fahy et al. 1997). 
A detailed clinical history was taken from each patient and they were asked to 
complete a validated hearing questionnaire, which is available on request (Chinnery et 
al. 2000).  All patients underwent otoscopy, followed by a comprehensive topographic 
neuro-auditory assessment to evaluate both middle and inner ear functions and the 
integrity of the brainstem auditory pathways.  The following measurements were 
carried out using standard test protocols as described previously (Chinnery et al. 
2000; Ceranic and Luxon 2004): (i) pure tone threshold audiometry, (ii) 
tympanometry, (iii) stapedial reflexes, (iv) oto-acoustic emissions (OAE), (v) speech 
audiometry and (vi) brainstem auditory evoked potential (BAEP).  The BAEP stimuli 
were clicks of 0.1ms duration, presented at a rate of 11 per second. The intensity was 
70dBnHL if the mean pure tone threshold at 2kHz and 4kHz was < 40dBHL, and 
80dBnHL if the mean threshold was ≥ 40dBHL. 
Results 
All of our patients were ≤ 55 years old at the time of recruitment (Mean age = 35) and 
the mean age of onset of visual loss was 21.  The primary LHON mutation was 
homoplasmic (100%), except in one patient (I) from a G11778A pedigree who was 
heteroplasmic at a mutational load of 95%.  One patient (F) had subjective hearing 
problems with his right ear and four patients (A, B, E and J) reported mild difficulty 
with hearing speech in noisy environments, which did not interfere with their daily 
activities.  The five other patients denied any hearing impairment (Table 1). 
  6 
None of our patients had evidence of an auditory neuropathy and five patients (A, B, 
C, G and I) had completely normal hearing tests.  The remainder had mild conductive 
hearing loss from childhood ear infections and/or high frequency sensorineural 
hearing loss from previous noise injury (Table 2).  The I-III and I–V interpeak 
latencies for patient D were borderline but his BAEP waveforms were normal and the 
changes in his pure tone and speech audiograms were consistent with a peripheral 
sensory problem and not a cochlear nerve or lower brain stem defect. 
Discussion 
Unlike Ceranic and Luxon, we found no evidence of auditory neuropathy in our larger 
cohort of affected LHON patients (Ceranic and Luxon 2004).  We did not include 
affected LHON patients ≥ 60 years of age in our study to avoid possible confounding 
factors in data analysis, since most people in this age group will have some degree of 
sensorineural hearing loss due to presbyacusis.  All of our patients were homoplasmic 
for the LHON mutation except for one who had a high mutational load of 95%.  
Heteroplasmy is therefore not a possible confounding factor as the mutant mtDNA 
will be either the sole or predominant species within the cells of the auditory 
apparatus and the central nervous system. 
Mondelli and colleagues investigated 11 patients in the pre-molecular era with a 
clinical diagnosis of LHON (Mondelli et al. 1990).  Although none of them reported 
any subjective hearing deficits and pure tone audiometry was entirely normal, 7 out of 
11 patients had BAEPs outside the normal range.  However, these abnormalities 
represented subtle changes and given that a complete auditory assessment was not 
performed, the actual significance of these BAEPs changes is unclear.  Funalot and 
colleagues followed a LHON patient with the T14484C mutation who at the age of 26 
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developed a cluster of symptoms including tinnitus, complete ophthalmoplegia, 
bilateral ptoses, gaze evoked nystagmus and ataxia (Funalot et al. 1996).  An MRI 
scan showed a lesion of high signal in the dorsal midbrain on T2 weighted images and 
his BAEP was abnormal with prolongation of the I-III interpeak interval.  This patient 
clearly had an atypical LHON phenotype with extensive neurological symptoms, and 
as such is part of the so-called “LHON +” syndrome.  Other more extensive “LHON 
+” pedigrees have been described where affected members experienced severe 
neurological deterioration including spastic dystonia, ataxia and juvenile onset 
encephalopathy, besides the optic neuropathy (Man et al. 2002).  However, with the 
exception of the patient described by Funalot and colleagues, hearing impairment was 
not a feature in any of these “LHON +” pedigrees.  There is therefore no strong 
correlation between a more severe LHON phenotype and an increased risk of auditory 
neuropathy. 
Several large case series of the 3 primary LHON mutations have also been published 
and none of them report significant hearing problems (Newman et al. 1991; 
Nikoskelainen et al. 1995; Riordan-Eva et al. 1995).  This is further supporting 
evidence for the lack of a strong association, with the caveat that formal auditory 
assessment was not carried out in these pedigrees and sub-clinical disease cannot be 
excluded.  Although further studies are required to confirm our findings, auditory 
dysfunction as a result of a primary LHON mutation is probably uncommon. 
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Table 1 
Clinical, molecular and auditory characteristics of LHON patients 
Patient Age 
(yrs) 
Sex Onset of Visual 
Loss (yrs) 
LHON 
Mutation 
Mutational 
Load (%) 
Current Hearing Symptoms Past ENT Problems 
A 35 M 22 G11778A 100 Difficulty understanding speech in 
crowded environments only 
None 
B 35 M N/A G11778A 100 Difficulty understanding speech in 
crowded environments only 
Otitis media (OME) in childhood and underwent 
tonsillectomy and adenoidectomy 
C 27 F 20 G3460A 100 None None 
D 55 M 39 G3460A 100 None None 
E 35 M 20 G11778A 100 Difficulty understanding speech in 
crowded environments only 
Reports frequent ear infections as a child but no 
surgical interventions 
F 30 M 21 G3460A 100 Reports poor hearing with his right ear Grommets inserted in both ears as a child for OME 
G 27 M 10 G11778A 100 None None 
H 26 M 20 T14484C 100 None Grommets inserted in both ears as a child for OME 
I 27 M 18 G11778A 95 None None 
J 55 M 15 T14484C 100 Difficulty understanding speech in 
crowded environments only 
None 
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Table 2 
Results and interpretation of hearing tests 
Patient Otoscopy 
L/R 
Pure Tone 
Audiogram 
Stapedial Reflexes BAEP Interpeak Latencies 
  Mean dB 
Loss† L/R 
Degree‡ 
L/R 
ART 
L/R 
ARD 
L/R 
OAE 
L/R 
Speech 
Audiogram 
L/R 
I−III L/R 
[1.75-2.45] 
III−V L/R 
[1.57-2.14] 
I−V L/R 
[3.54-4.36] 
Notes 
A N/N -3/2 N/N N/N N/N N/N N/N 2.28/2.32 1.76/1.88 4.08/4.16 Normal 
B N/N 5/7 N/N Bor/Bor Nt/Nt N/N N/N 2.16/2.20 1.92/1.76 4.05/3.96 Normal 
C N/N 4/6 N/N N/N N/N N/N N/N 2.04/2.16 2.08/1.92 4.12/4.08 Normal 
D N/N 15/23 N/Mild N/A N/Nt N/N ≈/≈ 2.48*/2.36 2.08/1.92 4.44*/4.40* Bilateral mild high frequency 
sensorineural hearing loss 
from past industrial noise 
exposure and right mild 
conductive hearing loss. 
E N/N 25/6 Mild/N N/N In/In Ab/N ≈/N 2.12/2.12 1.80/2.12 3.92/4.24 Mild conductive hearing loss 
L>R. 
F N/A 10/25 N/Mild In/Bor In/N N/Ab N/≈ 2.24/2.20 2.00/2.04 4.24/4.24 Right tympanic membrane 
scarred.  Right mild 
conductive hearing loss. 
G N/N 5/2 N/N N/N N/N N/N N/N 2.36/2.20 1.76/1.84 4.12/4.04 Normal 
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H A/A 15/9 N/N N/N Nt/Nt N/N ≈/≈ 2.16/2.16 2.16*/2.04 4.32/4.20 Bilateral tympanosclerosis.  
Left mild high frequency 
conductive hearing loss. 
I N/N -1/3 N/N N/N N/N N/N N/N 2.24/2.28 1.80/2.04 4.04/4.32 Normal 
J N/N 17/11 N/N N/N N/N N/N ≈/≈ 2.32/2.20 2.00/1.96 4.32/4.16 Bilateral mild high frequency 
sensorineural hearing loss 
from recreational noise 
exposure. 
 
L/R = left/right ear, A = abnormal, Ab = absent, ART = acoustic reflex threshold, ARD = acoustic reflex decay, Bor = borderline, dB = decibel, 
dBHL = decibel hearing level, In = inconclusive due to unstable baseline, N = normal, Nt = not tested, ≈ = as expected from abnormalities in the 
pure tone audiogram. 
† = mean hearing loss averaged over five frequencies (250, 500, 1000, 2000 and 4000 Hz), ‡ = severity: normal ≤ 20 dBHL, mild 20-40 dBHL, 
moderate 41-70 dBHL, severe 71-95 dBHL, profound > 95 dBHL. 
BAEP: [ ] = mean ± 2SD, * = value exceeds the 95% but not the 99% upper normal limit. 
 
  12 
References 
Ceranic B, Luxon LM (2004) Progressive auditory neuropathy in patients with 
Leber's hereditary optic neuropathy. J. Neurol. Neurosurg. Psychiatry 75:626-
630 
Chinnery PF, Elliott C, Green GR, Rees A, Coulthard A, Turnbull DM, Griffiths TD 
(2000) The spectrum of hearing loss due to mitochondrial DNA defects. Brain 
123:82-92 
Fahy E, Nazarbaghi R, Zomorrodi M, Herrnstadt C, Parker WD, Davis RE, Ghosh SS 
(1997) Multiplex fluorescence-based primer extension method for quantitative 
mutation analysis of mitochondrial DNA and its diagnostic application for 
Alzheimer's disease. Nucleic Acids Res. 25:3102-3109 
Funalot B, Ranoux D, Mas JL, Garcia C, Bonnefont JP (1996) Brainstem involvement 
in Leber's hereditary optic neuropathy: Association with the 14,484 
mitochondrial DNA mutation. J. Neurol. Neurosurg. Psychiatry 61:533-534 
Man PYW, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF (2003) 
The epidemiology of Leber hereditary optic neuropathy in the North East of 
England. Am J Hum Genet 72:333-339 
Man PYW, Turnbull DM, Chinnery PF (2002) Leber hereditary optic neuropathy. J 
Med Genet 39:162-169 
Mondelli M, Rossi A, Scarpini C, Dotti MT, Federico A (1990) BAEP Changes in 
Leber's Hereditary Optic Atrophy - Further Confirmation of Multisystem 
Involvement. Acta Neurol Scand 81:349-353 
  13 
Newman NJ, Lott MT, Wallace DC (1991) The clinical characteristics of pedigrees of 
Leber's hereditary optic neuropathy with the 11778 mutation. Am J 
Ophthalmol 111:750-62 
Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P, 
Savontaus ML (1995) Leber's "plus": neurological abnormalities in patients 
with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 
59:160-4 
Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE 
(1995) The clinical features of Leber's hereditary optic neuropathy defined by 
the presence of a pathogenic mitochondrial DNA mutation. Brain 118:319-37 
Spruijt L, Kolbach DN, de Coo RF, Plomp AS, Bauer NJ, Smeets HJ, de Die-
Smulders CEM (2006) Influence of mutation type on clinical expression of 
Leber hereditary optic neuropathy. Am J Ophthalmol 141:676-682 
 
